Choosing drugs for UK COVID-19 treatment trials

Metadata

Item Type:	Article
Authors/Creators:	Chinnery, PF Bonnet, M Cave, A Hofer, MP Lamb, A McConkey, GA https://orcid.org/0000-0001-6529-794X Medcalf, N Smith, SP Tsakok, T Watson, R Webster, S You, T
Copyright, Publisher and Additional Information:	This item is protected by copyright. This is an author produced version of a commentary published in Nature Reviews Drug Discovery. Uploaded in accordance with the publisher's self-archiving policy.
Dates:	Accepted: 23 November 2021 Published (online): 7 December 2021 Published: 1 February 2022
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Biology (Leeds)
Date Deposited:	09 Dec 2021 14:49
Last Modified:	09 Jul 2026 06:31
Status:	Published
Publisher:	Nature Research
Identification Number:	10.1038/d41573-021-00203-7
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:181391

CORE (COnnecting REpositories)